Results 111 to 120 of about 10,985 (213)

Diagnostic and therapeutic challenges of cutaneous leishmaniasis in Canada: A case report. [PDF]

SAGE Open Med Case Rep
Yu AC, Chan AR, Tse-Chang A, Waldner D, Fernando Sanchez-Espino L.   +4 more
europepmc   +1 more source

The Upcoming Antifungal Drugs in Clinical Development for the Treatment of Invasive Candidiasis. [PDF]

Infect Drug Resist
Zubovskaia A, Vazquez JA.
europepmc   +1 more source

Comparative <i>in vitro</i> susceptibility of clinical <i>Leishmania</i> isolates to miltefosine and oleylphosphocholine. [PDF]

Front Pharmacol
Khamesipour A, Tasbihi M, Mohammadi AMA, Dixon J, Clark DJ, Staines HM, Krishna S, Yardley V, Croft SL, Alexander N, Van Bocxlaer K.   +10 more
europepmc   +1 more source

Miltefosine in visceral leishmaniasis.

, 2003
Bryceson, Anthony DM, Engel, Jurgen, Olliaro, Piero L, Ridley, Robert G, Sindermann, Herbert   +4 more
core   +1 more source

Current issues in the treatment of visceral leishmaniasis. [PDF]

, 2001
Bryceson, A
core   +1 more source

Computational identification of <i>Azadirachta indica</i> compounds targeting trypanothione reductase in <i>Leishmania infantum</i>. [PDF]

Bioinform Adv
Samson OO, Samuel O, Ignatius FA, Adelonpe OT, Abdul M, Oladipo K, Esther AT, Omotara R, Nour H, Chtita S.   +9 more
europepmc   +1 more source

Antileishmanial and Immunomodulatory Activity of Paclitaxel and Docetaxel Combined with Miltefosine and Paromomycin. [PDF]

Int J Mol Sci
Melcón-Fernández E, Balaña-Fouce R, García-Estrada C, Reguera RM, Fernández-Rubio C, Cendón-Álvarez M, Pérez-Pertejo Y.   +6 more
europepmc   +1 more source

Combination therapy success in refractory pediatric visceral leishmaniasis with hemophagocytic lymphohistiocytosis: A case report. [PDF]

Medicine (Baltimore)
Masood RZ, Nikeeta F, Altaf A, Jabrieh G.   +3 more
europepmc   +1 more source

Immunotherapeutics Combining a Recombinant Chimeric Protein, Monophosphoryl Lipid A, and Miltefosine Against Visceral Leishmaniasis. [PDF]

Pathogens
Jesus MM, Lage DP, Pimenta BL, Moreira GJL, Pereira IAG, Câmara RSB, Silva AL, Tavares GSV, Falcão KOM, Dias SSG, Abrão DM, Rodrigues MM, Oliveira-da-Silva JA, Giusta MS, Chávez-Fumagalli MA, Roatt BM, Galdino AS, Christodoulides M, Freitas CS, Coelho EAF.   +19 more
europepmc   +1 more source

CRISPR-Cas13b mediated gene knockdowns in Leishmania infantum. [PDF]

Int J Parasitol Drugs Drug Resist
Queffeulou M, Fakhfakh R, Fani F, Dos Santos A, Reis Ferreira G, Bigot S, Godin C, Leprohon P, Papadopoulou B, Ouellette M.   +9 more
europepmc   +1 more source